0001209191-21-035364.txt : 20210524 0001209191-21-035364.hdr.sgml : 20210524 20210524165250 ACCESSION NUMBER: 0001209191-21-035364 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210520 FILED AS OF DATE: 20210524 DATE AS OF CHANGE: 20210524 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mack David Henry CENTRAL INDEX KEY: 0001341642 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39539 FILM NUMBER: 21955705 MAIL ADDRESS: STREET 1: ONE EMBARCADERO CENTER, SUITE 3700 CITY: SAN FRANCISCO STATE: CA ZIP: 94111 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PMV Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001699382 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 463218129 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 8 CLARKE DRIVE CITY: CRANBURY STATE: NJ ZIP: 08512 BUSINESS PHONE: (609) 642-6664 MAIL ADDRESS: STREET 1: 8 CLARKE DRIVE CITY: CRANBURY STATE: NJ ZIP: 08512 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-05-20 0 0001699382 PMV Pharmaceuticals, Inc. PMVP 0001341642 Mack David Henry C/O PMV PHARMACEUTICALS, INC. 8 CLARKE DRIVE, SUITE 3 CRANBURY NJ 08512 1 1 0 0 President and CEO Common Stock 2021-05-20 4 M 0 7793 0.53 A 10263 D Common Stock 2021-05-20 4 S 0 7793 35.6031 D 2470 D Common Stock 2021-05-21 4 M 0 6207 0.53 A 8677 D Common Stock 2021-05-21 4 S 0 6207 35.7083 D 2470 D Common Stock 227915 I See footnote Common Stock 56978 I See footnote Stock Option (right to buy) 0.53 2021-05-20 4 M 0 7793 0.00 D 2025-05-11 Common Stock 7793 492867 D Stock Option (right to buy) 0.53 2021-05-21 4 M 0 6207 0.00 D 2025-05-11 Common Stock 6207 485074 D The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 29, 2020. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.53 to $35.90, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.53 to $35.99, inclusive. The shares are held of record by The Mack-Mulligan Revocable Trust, for which the Reporting Person serves as co-trustee. The shares are held of record by the Mack/Mulligan 2020 Irrevocable Descendants' Trust, for which the Reporting Person serves as co-trustee. The shares subject to the option are fully vested and immediately exercisable. /s/ David H. Mack 2021-05-24